국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
risperidone, Quantity: 4 mg
Lupin Australia Pty Limited
Risperidone
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; pregelatinised maize starch; lactose monohydrate; sodium lauryl sulfate; purified talc; magnesium stearate; titanium dioxide; hypromellose; propylene glycol; iron oxide red
Oral
60 tablets
(S4) Prescription Only Medicine
Risperidone tablet is indicated for the treatment of schizophrenia and related psychoses. Risperidone tablet is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. Risperidone tablet is indicated for the treatment of behavioural disturbances in dementia. Risperidone tablet is indicated in the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. Risperidone tablet is indicated for the treatment of behavioural disorders associated with autism in children and adolescents.
Visual Identification: Red brown, capsule-shaped, biconvex film-coated tablet, debossed '4' on one side and break line on the other side.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2008-07-07
CONSUMER MEDICINE INFORMATION RISPERIBELL TABLETS RISPERIDONE (Lupin Australia Pty. Ltd.) CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Risperibell tablets. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT RISPERIBELL TABLETS ARE USED FOR Risperibell tablets are used to treat symptoms of schizophrenia and other types of related psychoses. These are disorders related to thought, feeling and/or action. Risperibell tablets may be taken for both sudden (acute) and long-lasting (chronic) schizophrenia. Risperibell tablets are also used for the short term treatment of acute mania associated with bipolar 1 disorder. This condition is characterised by symptoms such as elevated, expansive or irritable mood, inflated self- esteem, decreased need for sleep, pressured speech, racing thoughts, distractability or poor judgement including disruptive or aggressive behaviours. Risperibell tablets are also used to treat behavioural problems in patients with a decline in mental ability (dementia). These problems include: aggression through words or action, morbid suspiciousness, agitation or wandering Risperibell tablets can be used to treat conduct and other disruptive behaviours such as aggression, impulsiveness and self-injury in children (over 5 years old), adolescents and adults who are intellectually disabled. Risperibell tablets can also be used to treat behavioural symptoms of autism in children and adolescents Risperibell tablets helps to correct a chemical imbalance in the brain associated with these conditions. Risperibell tablets have been approved for the uses mentioned above. However, your doctor may prescribe this medicine for another use. If you want more information, ask your doctor. Risperibell tablets are not addictive. Page 2 of 10 B 전체 문서 읽기
PRODUCT INFORMATION RISPERIBELL TABLETS (LUPIN AUSTRALIA PTY. LTD) NAME OF THE MEDICINE: Risperidone is chemically identified as 3-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)-1-piperidinyl] ethyl]-6, 7, 8, 9-tetrahydro-2- methyl-4_H_-pyrido[1, 2-_a_]pyrimidin-4-one. Empirical formula C 23 H 27 FN 4 O 2 Molecular Weight: 410.49 CAS: 106266-06-2 DESCRIPTION: Risperidone is a novel antipsychotic belonging to a new class of antipsychotic agents, the benzisoxazole-derivatives. Each tablet contains 1 mg, 2 mg, 3 mg or 4mg of risperidone and following inactive ingredients: lactose, pregelatinised maize starch, microcrystalline cellulose, magnesium stearate, colloidal anhydrous silica, sodium lauryl sulphate, purified talc. In addition the 1 mg tablet contains hypromellose (E464), titanium dioxide (E171) and propylene glycol (E1520), the 2 mg tablet contains hypromellose (E464), titanium dioxide (E171), propylene glycol (E1520), FD and C yellow # 6/sunset yellow FCF aluminum lake (E110), the 3 mg tablet contains hypromellose (E464), iron oxide yellow (E172), titanium dioxide (E171), and propylene glycol (E1520) and the 4 mg tablet contains hypromellose (E464), titanium dioxide (E171), propylene glycol (E1520), iron oxide red (E172). _ _ 1506 Risperibell PI v3 ref: 04/2015 Page 2 of 33 PHARMACOLOGY: PHARMACODYNAMICS Risperidone is a selective monoaminergic antagonist with a high affinity for serotoninergic 5-HT 2 and dopaminergic D 2 receptors. Risperidone binds also to alpha 1 -adrenergic receptors, and with lower affinity, to H 1 -histaminergic and alpha 2 - adrenergic receptors. Risperidone has no affinity for cholinergic receptors. The antipsychotic activity of risperidone is considered to be attributed to both. risperidone and its active metabolite 9-hydroxy risperidone. Central dopamine D 2 receptor antagonism is considered to be the mechanism of action by which conventional neuroleptics improve the positive symptoms of schizophrenia, but also induce extrapyramidal symptoms and release of prolactin. Although risperidone 전체 문서 읽기